Unlocked Renewable Electricity for the Pharmaceutical Supply Chain
The global healthcare system accounts for nearly 5% of global emissions. In particular, scope 3 emissions account for more than 80% of a company’s emissions, making it the largest and toughest emission type to address. In partnership with Schneider Electric, 21+ of the world’s leading pharmaceutical organizations are collaborating to reduce their Scope 3 emissions by providing their suppliers access to critical education and renewable electricity procurement support through the Energize program. Energize is a first-of-its-kind program designed to accelerate adoption of renewable electricity across the global pharmaceutical supply chain.
This panel discussion will delve into the challenges of supply chain decarbonization and highlight significant milestones achieved through the Energize program. Hear firsthand accounts from Energize sponsors Takeda and BMS and a participating industry supplier on the success of a collective journey towards a sustainable future. Stay tuned for announcement of the panel of speakers.